1-5 of 5
Till Seiler, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low Incidence of Tumor Lysis Syndromes (TLS) and Infusion Related Reactions (IRR) in the CLL2-Bag Trial Evaluating a Sequential Treatment of Bendamustine (B), Obinutuzumab (GA101, G) and Venetoclax (ABT-199, A) in Patients with Chronic Lymphocytic Leukemia (CLL): Interim Safety Results of a Phase-II-Trial of the German CLL Study Group (GCLLSG)

Paula Cramer, MD, Julia von Tresckow, MD, Jasmin Bahlo, PhD, Sandra Robrecht, Anja Engelke, MD, Petra Langerbeins, MD, Anna-Maria Fink, MD, Hyatt Balke-Want, MD, Othman Al-Sawaf, MD, Till Seiler, MD, Ludwig Fischer von Weikersthal, MD, Holger Hebart, MD, Kirsten Fischer, MD, Clemens-Martin Wendtner, MD, Stephan Stilgenbauer, Barbara F. Eichhorst, MD, Michael Hallek
Journal: Blood
Blood (2016) 128 (22): 2044.
https://doi.org/10.1182/blood.V128.22.2044.2044
Published: 2016
Journal Articles

Results of the Safety Run-in Phase of CLL14 (BO25323): A Prospective, Open-Label, Multicenter Randomized Phase III Trial to Compare the Efficacy and Safety of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) with Obinutuzumab and Chlorambucil in Patients with Previously Untreated CLL and Coexisting Medical Conditions

Kirsten Fischer, MD, Anna-Maria Fink, MD, Helen Bishop, Mark Dixon, Jasmin Bahlo, Michael Y. Choi, MD, Robert Weinkove, MD PhD, K. Sue Robinson, MD, Martin Dreyling, MD PhD, Till Seiler, MD, Stephen Opat, MD, Carolyn Owen, MD, Javier Lopez, Sr., MD PhD, Nadine Kutsch, MD, Eugen Tausch, MD, Matthias Ritgen, MD, Rod A. Humerickhouse, MD PhD, Kathryn Humphrey, Michael K. Wenger, MD, Valentin Goede, MD, Barbara Eichhorst, MD, Clemens-Martin Wendtner, MD, Stephan Stilgenbauer, MD, Thomas J. Kipps, MD PhD, Michael Hallek, MD
Journal: Blood
Blood (2015) 126 (23): 496.
https://doi.org/10.1182/blood.V126.23.496.496
Published: 2015
Journal Articles

BCRs of Mutated and Unmutated CLL Bind Peptides with Distinct Sequence Features: Evidence from Phage Display Libraries.

Manuela Woelfle, MD, Till Seiler, MD, Rosa Catera, PhD, Hartmut Dohner, MD, Stephan Stilgenbauer, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Charles C. Chu, PhD, Nicholas Chiorazzi, MD
Journal: Blood
Blood (2007) 110 (11): 1118.
https://doi.org/10.1182/blood.V110.11.1118.1118
Published: 2007
Journal Articles

Binding of CLL B-Cell Receptors to Viable and Apoptotic Human Cells Offers Insight into the Role of Autoantigens in Leukemic Transformation.

Rosa Catera, PhD, Katerina Hatzi, BA, Till Seiler, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Charles C. Chu, PhD, Nicholas Chiorazzi, MD
Journal: Blood
Blood (2007) 110 (11): 741.
https://doi.org/10.1182/blood.V110.11.741.741
Published: 2007
Journal Articles

Short Telomeres Are Associated with Genetic Instability and the Occurrence of High Risk Genomic Aberrations in Chronic Lymphocytic Leukemia.

Alexander Kröber, MD, Pawel Grabowski, MD, Andreas Bühler, Till Seiler, MD, Hartmut Döhner, MD, Richard Rosenquist, MD, Göran Roos, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2005) 106 (11): 1178.
https://doi.org/10.1182/blood.V106.11.1178.1178
Published: 2005